Work

Lymphocyte Reconstitution Patterns in People with MS Being Treated with Rituximab After Alemtuzumab to Reduce the Frequency of Autoimmune Adverse Events in the RAMBLE Trial (P12-1.001)

FWCI:
Cites:
Cited by:
Related to: 10